Zhao Jun, Nussinov Ruth, Wu Wen-Jin, Ma Buyong
Division of Biotechnology Review and Research I, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA.
Interagency Oncology Task Force (IOTF) Fellowship: Oncology Product Research/Review Fellow, National Cancer Institute, Bethesda, MD 20892, USA.
Antibodies (Basel). 2018 Jun 29;7(3):22. doi: 10.3390/antib7030022.
Antibody therapies with high efficiency and low toxicity are becoming one of the major approaches in antibody therapeutics. Based on high-throughput sequencing and increasing experimental structures of antibodies/antibody-antigen complexes, computational approaches can predict antibody/antigen structures, engineering the function of antibodies and design antibody-antigen complexes with improved properties. This review summarizes recent progress in the field of in silico design of antibodies, including antibody structure modeling, antibody-antigen complex prediction, antibody stability evaluation, and allosteric effects in antibodies and functions. We listed the cases in which these methods have helped experimental studies to improve the affinities and physicochemical properties of antibodies. We emphasized how the molecular dynamics unveiled the allosteric effects during antibody-antigen recognition and antibody-effector recognition.
高效低毒的抗体疗法正成为抗体治疗的主要方法之一。基于高通量测序以及抗体/抗体-抗原复合物实验结构的不断增加,计算方法可以预测抗体/抗原结构、改造抗体功能并设计具有改进特性的抗体-抗原复合物。本综述总结了抗体计算机辅助设计领域的最新进展,包括抗体结构建模、抗体-抗原复合物预测、抗体稳定性评估以及抗体中的变构效应和功能。我们列举了这些方法有助于实验研究提高抗体亲和力和理化性质的案例。我们强调了分子动力学如何揭示抗体-抗原识别和抗体-效应器识别过程中的变构效应。